Full Breakdown
Nestlé Expands Infant Formula Recall Amid Toxin Concerns
2/4/2026, 10:04:36 PM
Overview of the Recall Expansion
Nestlé has broadened its recall of infant formula to include additional batches of Guigoz following France's decision to lower the maximum allowable level of cereulide, a toxin associated with gastrointestinal symptoms. This move contradicts previous analyst expectations that no further withdrawals would be necessary. The contamination has been traced back to ingredients supplied by a Chinese factory, impacting multiple infant formula manufacturers, including Danone and Lactalis.
Background on Cereulide Contamination
Cereulide is a heat-stable toxin produced by certain strains of Bacillus cereus, which can cause nausea and vomiting when consumed in significant amounts. The European Commission recently mandated that member states analyze both liquid and powdered infant formulas for cereulide levels, as liquid formulas may exhibit higher toxin concentrations. Nestlé's internal limit for cereulide is set at 0.2 ng/g, which is more stringent than the new European Food Safety Authority (EFSA) guideline of 0.43 ng/g.
Timeline of Events
- Late November 2025: Nestlé first detected low levels of cereulide in product samples.
- December 24, 2025: The company confirmed that an oil blend containing arachidonic acid oil was the source of contamination.
- January 31, 2026: France reduced its safety limit for cereulide, aligning with EFSA recommendations.
- February 2, 2026: EFSA introduced its updated threshold for cereulide levels.
- February 4, 2026: Nestlé announced the expansion of its recall to include additional batches of Guigoz.
Official Statements & Responses
Nestlé stated, “In light of the evolved EU method of analysis, and continuing to apply our strict internal standards for cereulide in infant formula, we are adding a few batches in some European countries that were already part of the initial recall.” The company did not specify the number of countries affected by the latest recall, but the initial recall had already impacted around 60 countries across Europe, Asia, and the Americas.
Criticism & Opposition
Despite the company's efforts, French investigators are currently examining a potential link between two infant deaths and the recalled Guigoz formula. Authorities and Nestlé have indicated that there is no evidence to support this connection at this time, but the investigation is ongoing, with results expected soon.
Market Impact
Following the announcement of the expanded recall, shares of Nestlé rose by 1.6%, while Danone's shares increased by 1.3%. Analysts from Barclays and Jefferies had previously indicated they did not foresee additional recalls for Nestlé or Danone as a result of the updated toxin limits.
Conflicting Reports & Gaps
While the recall has raised significant concerns among parents and prompted investigations, there remains no conclusive evidence linking the recalled products to the reported infant deaths. The situation continues to evolve as health authorities and Nestlé await further investigation results.
